Ketones, omega-3 fatty acids and the Yin-Yang balance in the brain: insights from infant development and Alzheimer's disease, and implications for human brain evolution

被引:6
|
作者
Cunnane, Stephen C. [1 ]
机构
[1] Univ Sherbrooke, Dept Med, Sherbrooke, PQ, Canada
基金
加拿大自然科学与工程研究理事会;
关键词
brain; brain development; Alzheimer's disease; glucose; ketones; beta-hydroxybutyrate; aging; omega-3 fatty acids; alpha-linolenic acid; eicosapentaenoic acid; docosahexaneoic acid;
D O I
10.1051/ocl/2018020
中图分类号
S3 [农学(农艺学)];
学科分类号
0901 ;
摘要
Optimal brain performance is intimately linked to the brain's Yin and the Yang - the balance between its structure and its energy metabolism. This relationship is clearly exemplified in infant brain development and in Alzheimer's disease, and probably also applies to human brain evolution. In these examples, redundant pathways help achieve this important balance. For instance, the key structural lipid for the brain, docosahexaenoic acid (DHA), is supplied to the infant brain from at last three overlapping sources: (i) milk; (ii) infant's own fat stores and (iii) by some endogenous synthesis from alpha-linolenic acid (ALA) or eicosapentaenoic acid (EPA). On the energy side, glucose is normally the brain's main fuel but under conditions of prolonged starvation, it can be almost totally replaced by the ketone bodies, acetoacetate and beta-hydroxybutyrate. When ketones are present in the blood they spare glucose uptake by the brain because they are actually the brain's preferred fuel and are essential for normal infant brain development. The redundant sources of ketones are long chain fatty acids (including the relatively ketogenic ALA) in infant stores, and medium chain triglycerides (MCT) in milk. Besides infancy, nowhere is the strain on the brain's balance between yin and yang more apparent than in Alzheimer's disease (AD). One of the reasons why attempts to treat AD have largely failed could well be because chronically inadequate glucose supply to some areas of the brain on the order of 10% is present in people at risk of AD long before cognitive decline begins. However, brain ketone uptake is still normal even in moderately advanced AD. Hence, treatments that ignore the brain energy (glucose) deficit in AD would be predicted to fail, but treatments that attempt to rescue brain fuel availability via ketones would be predicted to have a better chance of succeeding. By analogy to ketones sparing glucose for brain energy metabolism, perhaps ALA or EPA entering the brain can help spare (conserve) DHA for its structural role. If so, it would not necessarily be futile to transport ALA and EPA into the brain just to beta-oxidize the majority afterwards; DHA sparing as well as ketone production could be important beneficiaries.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Protective effects of omega-3 fatty acids against Alzheimer's disease in rat brain endothelial cells
    Wang, Lijun
    Fan, Hongguang
    He, Jingchun
    Wang, Lifang
    Tian, Zelong
    Wang, Chaoran
    BRAIN AND BEHAVIOR, 2018, 8 (11):
  • [2] Modulation of inflammation in Alzheimer's disease and omega-3 fatty acids
    Szczechowiak, Katarzyna
    Wojcik, Daniel
    AKTUALNOSCI NEUROLOGICZNE, 2019, 19 (01): : 27 - 32
  • [3] Omega-3 fatty acids and lipoic acid in Alzheimer's disease
    Shinto, Lynne
    Quinn, Joseph
    Montine, Thomas
    Baldauf-Wagner, Sara
    Bourdette, Dennis
    Oken, Barry
    Kaye, Jeffrey
    NEUROLOGY, 2008, 70 (11) : A393 - A393
  • [4] Omega-3 fatty acids, cognitive impairment and Alzheimer's disease
    Phillips, M. A.
    REVIEWS IN CLINICAL GERONTOLOGY, 2010, 20 (03) : 219 - 238
  • [5] Role of omega-3 fatty acids in brain development and function: Potential implications for the pathogenesis and prevention of psychopathology
    McNamara, Robert K.
    Carlson, Susan E.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2006, 75 (4-5): : 329 - 349
  • [6] Omega-3 fatty acids' supplementation in Alzheimer's disease: A systematic review
    Canhada, Scheine
    Castro, Kamila
    Perry, Ingrid Schweigert
    Luft, Vivian Cristine
    NUTRITIONAL NEUROSCIENCE, 2018, 21 (08) : 529 - 538
  • [7] A Recent Update on the Effects of Omega-3 Fatty Acids in Alzheimer's Disease
    Ajith, Thekkuttuparambil Ananthanarayanan
    CURRENT CLINICAL PHARMACOLOGY, 2018, 13 (04): : 252 - 260
  • [8] Omega-3 polyunsaturated fatty acids promote brain-to-blood clearance of β-Amyloid in a mouse model with Alzheimer's disease
    Yan, Lingli
    Xie, Youna
    Satyanarayanan, Senthil Kumaran
    Zeng, Haitao
    Liu, Qiang
    Huang, Miaodan
    Ma, Yuemeng
    Wan, Jian-Bo
    Yao, Xiaoli
    Su, Kuan-Pin
    Su, Huanxing
    BRAIN BEHAVIOR AND IMMUNITY, 2020, 85 : 35 - 45
  • [9] Omega-3 fatty acids: potential role in the management of early Alzheimer's disease
    Jicha, Gregory A.
    Markesbery, William R.
    CLINICAL INTERVENTIONS IN AGING, 2010, 5 : 45 - 61
  • [10] Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids
    Fiala, Milan
    Kooij, Gijs
    Wagner, Karen
    Hammock, Bruce
    Pellegrini, Matteo
    FASEB JOURNAL, 2017, 31 (08): : 3229 - 3239